Prof. Hitoshi Okazawa
- Professor, Pathophysiology and Neuropathology,
Graduate School of Medical and Dental Sciences, Medical Research Institute, Tokyo Medical and Dental University
Neurologist and Neuroscientist.
MD, PhD, The University of Tokyo, School of Medicine
After becoming a staff member at theDepartment of Neurology of The University of Tokyo, Prof. Okazawa obtained his PhD degree in 1991 upon discovering Oct-3/4:Oct-4:Oct-3 (Cell1990; EMBO J 1991), which is now well known as a key regulator of ES cells and is the most important factor for generating iPS cell. After working at the Max Planck Institute for Psychiatry as a staff scientist, Prof. Okazawa was made an assistant professor (Department of Neurology, The University of Tokyo) and started researching polyglutamine diseases. His research scope expanded to include mental retardation and microcephaly, after the discovery of polyglutamine binding protein-1 (PQBP1) (Hum Mol Genet 1999; Neuron 2002). In 2001 he became the Head, Tokyo Metropolitan Institute for Neuroscience; in 2003, he was named Professor and Chair, Neuropathology, Tokyo Medical and Dental University.
- Prof. Okazawa's ISP2012 Symposium Talk Abstract:
- Pathomechanisms of Intellectual Disabilities linked to a new RNA splicing protein, PQBP1
- Prof. Okazawa's TMDU Research Profile:
- English | 日本語